This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer
Scientific Reports Open Access 29 October 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Allison, M. Clinical setbacks reduce IGF-1 inhibitors to cocktail mixers. Nat Biotechnol 30, 906–907 (2012). https://doi.org/10.1038/nbt1012-906c
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1012-906c